Patent · US Active

Compositions and methods for treating retinal diseases

US12410399B2 · kind B2 · utility

0Cited by
9References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 7, 2023
Grant dateSep 9, 2025
Priority date
Expiry dateAug 26, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2533/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells. The subject matter described herein also provides cell populations comprising retinal progenitor cells and methods of isolation thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.